167 related articles for article (PubMed ID: 16430776)
1. Prognosis of screen-detected breast cancers: results of a population based study.
Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
[TBL] [Abstract][Full Text] [Related]
2. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening.
Arnesson LG; Smeds S; Fagerberg G
Eur J Surg; 1994 May; 160(5):271-6. PubMed ID: 8075195
[TBL] [Abstract][Full Text] [Related]
3. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
4. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
5. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
Zackrisson S; Janzon L; Manjer J; Andersson I
J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
[TBL] [Abstract][Full Text] [Related]
6. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
7. A 13-year follow-up of patients with breast cancer presenting to a District General Hospital breast unit in southeast England.
Robinson D; Bell J; Møller H; Salman A
Breast; 2006 Apr; 15(2):173-80. PubMed ID: 16081289
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
9. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
Jensen AR; Madsen AH; Overgaard J
Acta Oncol; 2008; 47(4):537-44. PubMed ID: 18465319
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prognostic and socio-economic factors in screen-detected and symptomatic cases of breast cancer.
Garvican L; Littlejohns P
Public Health; 1998 Jan; 112(1):15-20. PubMed ID: 9490883
[TBL] [Abstract][Full Text] [Related]
11. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival.
Aarts MJ; Voogd AC; Duijm LE; Coebergh JW; Louwman WJ
Breast Cancer Res Treat; 2011 Jul; 128(2):517-25. PubMed ID: 21290176
[TBL] [Abstract][Full Text] [Related]
13. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
14. Interval breast cancers: prognostic features and survival by subtype and time since screening.
Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J
J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan.
Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C
Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721
[TBL] [Abstract][Full Text] [Related]
16. Survival rates for breast cancers detected in a community service screening mammogram program.
Sener SF; Winchester DJ; Winchester DP; Barrera E; Bilimoria M; Brinkmann E; Alwawi E; Rabbitt S; Schermerhorn M; Du H
Am J Surg; 2006 Mar; 191(3):406-9. PubMed ID: 16490556
[TBL] [Abstract][Full Text] [Related]
17. Screen-detected breast cancers have a lower mitotic activity index.
Groenendijk RP; Bult P; Tewarie L; Peer PG; van der Sluis RF; Ruers TJ; Wobbes T
Br J Cancer; 2000 Jan; 82(2):381-4. PubMed ID: 10646892
[TBL] [Abstract][Full Text] [Related]
18. Twenty-year review of a breast cancer screening project. Ninety-five percent survival of patients with nonpalpable cancers.
Letton AH; Mason EM; Ramshaw BJ
Cancer; 1996 Jan; 77(1):104-6. PubMed ID: 8630914
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
Seppänen J; Heinävaara S; Holli K; Hakulinen T
Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
[TBL] [Abstract][Full Text] [Related]
20. [Population screening for breast cancer: an interim assessment].
van der Maas PJ
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
